The Food and Drug Administration (FDA) published proposed guidance on April 22nd for a voluntary expedited access program for new high-risk medical devices that are intended to treat or diagnose patients with serious conditions that are unaddressed...
By: Foley & Lardner LLP
By: Foley & Lardner LLP